Episode 213: Arun Ananth and Tom Gallo - Data As An Asset With Proscia’s Diagnostic Network

Today my guests are Arun Ananth, CCO and Tom Gallo, CFO from Proscia.

What we discuss with Arun and Tom:

• Introduction to Proscia’s Diagnostic Network
• Reshaping the economics of pathology
• Economic opportunities in digital pathology
• Data as an asset in biomarker discovery
• Clinical trials as use cases
• Compliance and security in digital pathology
• Pathology's central role in treatment
• Accelerating digital adoption and ROI
• Patient benefits and clinical trials
• Risks and barriers in digital pathology
• Advice for labs considering digital pathology
• Market adoption and future vision

Links for this episode:

The Path to PathA

Pathologists' Assistant Shadowing Network

Health Podcast Network

 LabVine Learning

Dress A Med scrubs

Digital Pathology Club

 

Proscia Cements Leadership in Diagnostic Pathology with 400% Growth in Daily Cases

Rewiring the Laboratory’s Bottom Line: Moving Towards Digital Pathology as a Profit Center

 

People of Pathology Podcast:

Twitter

Instagram